Explore more publications!

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on October 17, 2025

Carson & Acasio Dentistry Upgrades to Latest CEREC Technology for Enhanced Same-Day Crown Services
Health Care Foundation for Ventura County Receives $2 Million Grant from Gold Coast Health Plan
Automation Alone Can’t Bring Ghosted Leads Back—Here’s What Works Instead
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
4DMT Announces New Employment Inducement Grants
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
Walnut Hill Dental in Pasadena, CA changes its Dental Office Name to Pasadena Dental Office and Orthodontics
ORYZON Receives Feedback From the FDA in Response to the Submitted Phase III Protocol in Borderline Personality Disorder
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
Wake Radiology Grows Breast Imaging Section with Five New Hires; Launches "We See the Difference" Campaign for Breast Cancer Awareness Month
Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Dr. Alyssa Dweck Shares Menopause Insights and Solutions on YourUpdateTV
Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke
Artios Announces Phase 1/2a Data for DNA Polymerase Theta Inhibitor ART6043 at ESMO Congress 2025
Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025
Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions